KRAS and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma cells, a non-canonical glutamine pathway mediated by the oncogene KRAS that regulates glutamic-oxaloacetic transaminase 1 (GOT1) and GLUD1 has been described12.